60 results
8-K
EX-4.2
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.5
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.4
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.3
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
8hhy9dg
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
EX-4.1
ufwgwgt4
30 Aug 22
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
4:30pm
8-K
EX-4.2
ra2jqqbuiaf4
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.3
f6qk7o dgtwwg
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.1
hkhddm11do
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.4
evzv84l1v1q2yt
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.1
8dmyptkr8 gq3izzc
8 Apr 21
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-4.1
lvwbkzn 72hq9
11 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.1
khx1f8zshc2ukhef
22 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-4.1
q356gh
29 Dec 20
Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar
5:03pm
8-K
EX-4.1
0ql1gud0r w8mkxetb
9 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-4.1
mv78vh2ujn3pld
9 Oct 20
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-4.1
50vyrcw
2 Sep 20
Entry into a Material Definitive Agreement
8:25am
8-K
EX-4.1
q2jcp7fhgsz6w822
22 May 20
Entry into a Material Definitive Agreement
5:25pm